MedPath

Cetirizine Hydrochloride

Cetirizine Hydrochloride Oral Solution, USP

Approved
Approval ID

2e2675ed-bcba-4ebc-99a7-2df6020db748

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 12, 2022

Manufacturers
FDA

Breckenridge Pharmaceutical, Inc.

DUNS: 150554335

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cetirizine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51991-837
Application NumberANDA078488
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cetirizine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJuly 12, 2022
FDA Product Classification

INGREDIENTS (11)

Cetirizine HydrochlorideActive
Quantity: 1 mg in 1 mL
Code: 64O047KTOA
Classification: ACTIB
bananaInactive
Code: 4AJZ4765R9
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
acetic acidInactive
Code: Q40Q9N063P
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
sodium acetateInactive
Code: 4550K0SC9B
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
sucroseInactive
Code: C151H8M554
Classification: IACT
grapeInactive
Code: 6X543N684K
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cetirizine Hydrochloride - FDA Drug Approval Details